Browsing Tag
Pharma acquisition news
231 posts
Allergan to sell brazikumab to AstraZeneca and Zenpep to Nestle
Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in…
January 27, 2020
Merck acquires ArQule for $2.7bn to further diversify oncology pipeline
Merck acquisition of ArQule : Merck has completed its previously announced acquisition of ArQule for $20 per share…
January 18, 2020
Lilly to acquire US dermatology drug company Dermira for $1.1bn
Lilly acquisition of Dermira : US pharma giant Eli Lilly and Company (Lilly) has agreed to acquire California-based…
January 13, 2020
NeuroBo, Gemphire merger wrapped up to form neurodegenerative disease company
NeuroBo Pharmaceuticals, a Boston-based clinical-stage pharma company, has wrapped up its previously announced merger with Gemphire Therapeutics, a…
January 13, 2020
Astellas Pharma acquires US biotech company Xyphos Biosciences
Astellas acquisition of Xyphos : Japanese pharma company Astellas Pharma has acquired US biotech company Xyphos Biosciences in…
December 28, 2019
HemaCare to be acquired by Charles River Laboratories for $380m
Charles River acquisition of HemaCare : Charles River Laboratories International, an early-stage contract research organization, has agreed to…
December 18, 2019
3M to sell drug delivery business to Altaris Capital for $650m
US industrial conglomerate 3M has signed a cash-cum-stock deal worth around $650 million to sell substantially all of…
December 13, 2019
Astellas Pharma to acquire US gene therapy company Audentes Therapeutics
Astellas acquisition of Audentes: Japanese pharma company Astellas Pharma has agreed to acquire US gene therapy company Audentes…
December 8, 2019
Janssen to acquire skin disease drug candidate bermekimab from XBiotech
Janssen Biotech acquisition of bermekimab: Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, has agreed to…
December 8, 2019
Novartis to acquire The Medicines Company for $9.7bn with eye on inclisiran
Novartis acquisition of The Medicines Company : Swiss drugmaker Novartis signed a deal worth $9.7 billion to acquire…
November 25, 2019